Results 121 to 130 of about 14,484 (178)
Which surfactant is cost-effective in Neonatal Respiratory Distress Syndrome? [PDF]
Nikakhtar G +4 more
europepmc +1 more source
Evidence Synthesis via Indirect Treatment Comparisons in the European Framework of Joint Clinical Assessment. [PDF]
Cuadra-Grande A +4 more
europepmc +1 more source
Lost in Translation? A Scoping Review to Explore the Translation and Cultural Adaptation of Preference-Based Measures of Quality of Life. [PDF]
Cleland J, Lay K, Ratcliffe J, Khadka J.
europepmc +1 more source
The Cost Utility of Rhythm Control Treatment Sequences in Patients with Atrial Fibrillation: Anti-arrhythmic Drugs Versus Catheter Ablation. [PDF]
Huygens S +5 more
europepmc +1 more source
Changes in the Use of Montelukast for Asthma After a US Food and Drug Administration Boxed Warning.
Shanmugam H +4 more
europepmc +1 more source
Pharmacoequity in Anticoagulation Among Medicare Patients With Venous Thromboembolism.
Alkhalaf AA +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Interventional Pharmacoeconomics
The Cancer Journal, 2020Abstract The increasing cost of health care is a major challenge around the world, but particularly in the United States. One reason for increased costs is the rapidly rising cost of oncology drugs. Potential solutions to this problem involve broad changes to health policy. However, an alternative solution is the development of lower-cost off-
Daniel A, Goldstein +5 more
openaire +2 more sources

